Helping Tobacco Users Quit Act

Support banning the sale of menthol cigarettes and flavored cigars Oppose S 107: Traditional Cigar Manufacturing and Jobs Act Support HR 4775: Helping Tobacco Users Quit Act - provide coverage of comprehensive tobacco cessation services

Client expense: $120,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to lung disease treatment, prevention and research; Issues related to tobacco cessation; Issues related to smokefree air; Issues related to the Tobacco Control Act; Issues related to tobacco smuggling; Issues related to the Affordable Care Act; Issues related to menthol cigarettes; Issues related to tobacco prevention; Issues related to youth cessation research; Issues related to nicotine; Issues related to health equity; Issues related to COVID-19 Response; Issues related to tobacco litter; Issues related to synthetic nicotine; Issues related to regulatory reform;; Issues relating to FY25 appropriations; Issues relating to the Presidents FY26 budget; HR 277 REINS Act; S 184 REINS Act; S. 107 Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2023; HR 901 To require the Food and Drug Administration to prioritize enforcement of disposable electronic nicotine delivery system products; S. 464 No Tax Subsidies for E-Cigarette and Tobacco Ads; HR 2811 Limit Save Grow Act; HR 442 Regulatory Accountability Act; S 1615 Regulatory Accountability Act;; HR 288 Separation of Powers Restoration Act of 2023;; HR 4020 Children Don't Belong on Tobacco Farms Act;; S 1411, Prove It Act of 2023; HR 4286 Increasing Access to Lung Cancer Screening Act; S 2213 Comprehensive Cancer Survivorship Act; HR 4363 Comprehensive Cancer Survivorship Act; HR 2398 To amend title 38, United States Code, to prohibit smoking on the premises of any facility of the Veterans Health Administration, and for other purposes.; S 1040 To amend title 38, United States Code, to prohibit smoking on the premises of any facility of the Veterans Health Administration, and for other purposes; ; HR 890 The Guidance Out of Darkness Act; S 791 The Guidance Out of Darkness Act; HR 4775 Helping Tobacco Users Quit Act; S 3108 Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction Act; HR 6038 Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction Act Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction Act; HR 357 Ensuring Accountability in Agency Rulemaking; SJ Res 99 Exclude premium cigars from FDA oversight; issues related to enforcement of illegal vaping; HR 7867 Renewing Efficiency in Government by Budgeting Act; HR 115 Midnight Rules Relief Act; HR 9027 Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2025; HR 9029 Departments of Labor, Health and Human Services, and Education and Related Agencies Appropriations Act, 2025; HR 9367 Preventing Vape Use Act; S. 4942 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025; S 4690 Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2025; HR 890 Guidance out of Regulatory Darkness Act; HR 9747 Continuing Appropriations and Extensions Act, 2025; HR 9494 Continuing Appropriations and Other Matters Act 2025

Client expense: $180,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office

Legislation and policies relating to: Adoption of recommendations of the National Academy of Medicine report, The Future of Nursing 2020-2030: Charting a Path to Achieve Health Equity Provisions of the Patient Protection & Affordable Care Act (P.L. 111-148) Reauthorization of the Childrens Health Insurance Program Reauthorization of the Child Nutrition Act Section 2706 of the ACA regarding provider non-discrimination Policies affecting nurse practitioner education and workforce Definition, evaluation and enforcement of essential health benefits and provider network adequacy Health information technology and electronic health records Mental health services and violence prevention H.R. 766/S 114, Dr. Michael C. Burgess Preventive Health Savings Act H.R. 1147/S. 1957, Whole Milk for Healthy Kids Act of 2023 H.R. 1843/S.1001, Telehealth Expansion Act of 2023 H.R. 1692, Health Care Affordability Act of 2023 H.R. 2411/S. 1150, National Nursing Workforce Centers Act of 2023 H.R. 2663/S. 1176, Workplace Violence Prevention for Health Care and Social Service Workers Act H.R. 2713/S. 2418, Improving Care and Access to Nurses (I CAN) Act H.R. 3073/S. 1452, Community Mental Wellness and Resilience Act of 2023 H.R 3226/S. 1573, PREEMIE Reauthorization Act of 2023 H.R. 3305/S. 1606, Black Maternal Health Momnibus Act H.R. 3331/S. 754, Improving Mental Health and Wellness in Schools Act H.R. 3633, Promoting Resources to Expand Vaccination, Education, and New Treatments for HPV Cancers (PREVENT HPV Cancers) Act of 2023 H.R. 4310/S. 2233, Youth Poisoning Protection Act H.R. 4581/S. 2231, Maternal and Child Health Stillbirth Prevention Act of 2023 H.R. 4758/S. 2372, Accelerating Kids Access to Care Act H.R. 4775, Helping Tobacco Users Quit Act H.R. 4892/S. 3921, Medicaid Bump Act H.R. 5012/S. 2647, Stillbirth Health Improvement and Education (SHINE) for Autumn Act of 2023 H.R. 5378, Lower Costs, More Transparency Act H.R. 6122/S. 2853, Train More Nurses Act H.R. 6149/S. 1291, Protecting Kids on Social Media Act H.R. 6766/S. 3512, Transparency, Readability, Understandability, Truth, and Helpfulness (TRUTH) in Labeling Act H.R. 6960/S. 3765, Emergency Medical Services for Children Reauthorization Act of 2024 H.R. 7002/S. 2815, Nurse Faculty Shortage Reduction Act of 2024 H.R. 7153/S. 3679, Dr. Lorna Breen Health Care Provider Protection Reauthorization Act H.R. 7224, To reauthorize the Stop, Observe, Ask, and Respond to Health and Wellness Training Program. H.R. 7808, Early Action and Responsiveness Lifts Youth (EARLY) Minds Act H.R. 8467, Farm, Food, and National Security Act of 2024 H.R. 8818, American Privacy Rights Act S. 8, Improving Health Insurance Affordability Act of 2023 S. 397, Promoting Physical Activity for Americans Act S.644/H.R. 1359, Modernizing Opioid Treatment Access Act S. 1409/H.R. 7891, Kids Online Safety Act S. 1418/H.R. 7890, Children and Teens Online Privacy Protection Act S. 1840/H.R. 3916, Screening for Communities to Receive Early and Equitable Needed Services (SCREENS) for Cancer Act of 2023 S. 1884/H.R. 3713, Mental Health Services for Students Act of 2023 S. 2840, Bipartisan Primary Care and Health Workforce Act S. 3085, Preventing Adverse Childhood Experiences (PACE) Act S. 3393/H.R. 4531, SUPPORT for Patients and Communities Reauthorization Act S. 3770/H.R. 7266, Future Advancement of Academic Nursing (FAAN) Act S. 4041, Creating Access and Resources in Education (CARE) for Student Mental Health Act S. 4532/H.R. 8702, Improving Seniors Timely Access to Care Act

Client expense: Not reported · Firm income: $24,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Helping Tobacco Users Quit Act (H.R. 4775, no bill number for Senate) Bipartisan Primary Care and Health Workforce Act (S. 2840; cuts to Prevention and Public Health Fund, which funds much of Office of Smoking and Health) Vetting and Patrolling E-Cigarette (VAPE) Imports Act (H.R. 7715, no bill number for Senate) Expressing the sense of the House of Representatives that public health authorities and tobacco control advocates should encourage American innovation and embrace harm reduction as part of the comprehensive United States approach to tobacco control. (H.Res. 979) Resources to Prevent Youth Vaping Act (S. 3653) A bill to require the Food and Drug Administration to establish a written enforcement plan with respect to certain electronic nicotine delivery systems, and for other purposes (no bill number) FDA action to remove menthol cigarettes from the market FDA action to remove flavored cigars from the market FDA regulation of synthetic nicotine FDA review of Premarket Tobacco Product applications FDA nicotine product standards FDA regulation of nicotine analog products FDA regulation of nicotine pouches FDA enforcement against unauthorized tobacco products

Client expense: $670,000 · Firm income: Not reported

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

Support banning the sale of menthol cigarettes and flavored cigars Oppose S 107: Traditional Cigar Manufacturing and Jobs Act Support HR 4775: Helping Tobacco Users Quit Act - provide coverage of comprehensive tobacco cessation services

Client expense: $540,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to lung disease treatment, prevention and research; Issues related to tobacco cessation; Issues related to smokefree air; Issues related to the Tobacco Control Act; Issues related to tobacco smuggling; Issues related to the Affordable Care Act; Issues related to menthol cigarettes; Issues related to tobacco prevention; Issues related to youth cessation research; Issues related to nicotine; Issues related to health equity; Issues related to COVID-19 Response; Issues related to tobacco litter; Issues related to synthetic nicotine; Issues related to regulatory reform;; Issues relating to FY25 appropriations; Issues relating to the Presidents FY26 budget; HR 277 REINS Act; S 184 REINS Act; S. 107 Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2023; HR 901 To require the Food and Drug Administration to prioritize enforcement of disposable electronic nicotine delivery system products; S. 464 No Tax Subsidies for E-Cigarette and Tobacco Ads; HR 2811 Limit Save Grow Act; HR 442 Regulatory Accountability Act; S 1615 Regulatory Accountability Act;; HR 288 Separation of Powers Restoration Act of 2023;; HR 4020 Children Don't Belong on Tobacco Farms Act;; S 1411, Prove It Act of 2023; HR 4286 Increasing Access to Lung Cancer Screening Act; S 2213 Comprehensive Cancer Survivorship Act; HR 4363 Comprehensive Cancer Survivorship Act; HR 2398 To amend title 38, United States Code, to prohibit smoking on the premises of any facility of the Veterans Health Administration, and for other purposes.; S 1040 To amend title 38, United States Code, to prohibit smoking on the premises of any facility of the Veterans Health Administration, and for other purposes; ; HR 890 The Guidance Out of Darkness Act; S 791 The Guidance Out of Darkness Act; HR 4775 Helping Tobacco Users Quit Act; S 3108 Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction Act; HR 6038 Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction Act Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction Act; HR 357 Ensuring Accountability in Agency Rulemaking; SJ Res 99 Exclude premium cigars from FDA oversight; issues related to enforcement of illegal vaping; HR 7867 Renewing Efficiency in Government by Budgeting Act; HR 115 Midnight Rules Relief Act; Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2025; Departments of Labor, Health and Human Services, and Education and Related Agencies Appropriations Act, 2025;

Client expense: $60,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office

Support banning the sale of menthol cigarettes and flavored cigars Oppose S 107: Traditional Cigar Manufacturing and Jobs Act Support HR 4775: Helping Tobacco Users Quit Act - provide coverage of comprehensive tobacco cessation services

Client expense: $200,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Legislation and policies relating to: Adoption of recommendations of the National Academy of Medicine report, The Future of Nursing 2020-2030: Charting a Path to Achieve Health Equity Provisions of the Patient Protection & Affordable Care Act (P.L. 111-148) Reauthorization of the Childrens Health Insurance Program Reauthorization of the Child Nutrition Act Section 2706 of the ACA regarding provider non-discrimination Policies affecting nurse practitioner education and workforce Definition, evaluation and enforcement of essential health benefits and provider network adequacy Health information technology and electronic health records Mental health services and violence prevention H.R. 766/S 114, Dr. Michael C. Burgess Preventive Health Savings Act H.R. 1147/S. 1957, Whole Milk for Healthy Kids Act of 2023 H.R. 1843/S.1001, Telehealth Expansion Act of 2023 H.R. 2411/S. 1150, National Nursing Workforce Centers Act of 2023 H.R. 2663/S. 1176, Workplace Violence Prevention for Health Care and Social Service Workers Act H.R. 2713/S. 2418, Improving Care and Access to Nurses (I CAN) Act H.R. 3073/S. 1452, Community Mental Wellness and Resilience Act of 2023 H.R 3226/S. 1573, PREEMIE Reauthorization Act of 2023 H.R. 3305/S. 1606, Black Maternal Health Momnibus Act H.R. 3331/S. 754, Improving Mental Health and Wellness in Schools Act H.R. 3633, Promoting Resources to Expand Vaccination, Education, and New Treatments for HPV Cancers (PREVENT HPV Cancers) Act of 2023 H.R. 4892/S. 3921, Medicaid Bump Act H.R. 4531/S. 3393, SUPPORT for Patients and Communities Reauthorization Act of 2023 H.R. 4581/S. 2231, Maternal and Child Health Stillbirth Prevention Act of 2023 H.R. 4758/S. 2372, Accelerating Kids Access to Care Act H.R. 4775, Helping Tobacco Users Quit Act H.R. 5012/S. 2647, Stillbirth Health Improvement and Education (SHINE) for Autumn Act of 2023 H.R. 5378, Lower Costs, More Transparency Act H.R. 6122/S. 2853, Train More Nurses Act H.R. 6766/S. 3512, Transparency, Readability, Understandability, Truth, and Helpfulness (TRUTH) in Labeling Act H.R. 6960/S. 3765, Emergency Medical Services for Children Reauthorization Act of 2024 H.R. 7002/S. 2815, Nurse Faculty Shortage Reduction Act of 2024 H.R. 7153/S. 3679, Dr. Lorna Breen Health Care Provider Protection Reauthorization Act H.R. 7224, To reauthorize the Stop, Observe, Ask, and Respond to Health and Wellness Training Program. S.644/H.R. 1359, Modernizing Opioid Treatment Access Act S. 1409, Kids Online Safety Act S. 1418, Children and Teens Online Privacy Protection Act S. 1840/H.R. 3916, Screening for Communities to Receive Early and Equitable Needed Services (SCREENS) for Cancer Act of 2023 S. 1884/H.R. 3713, Mental Health Services for Students Act of 2023 S. 2840, Bipartisan Primary Care and Health Workforce Act S. 3085, Preventing Adverse Childhood Experiences (PACE) Act S. 3393/H.R. 4531, SUPPORT for Patients and Communities Reauthorization Act S. 3770/H.R. 7266, Future Advancement of Academic Nursing (FAAN) Act

Client expense: Not reported · Firm income: $24,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Issues related to lung disease treatment, prevention and research; Issues related to tobacco cessation; Issues related to smokefree air; Issues related to the Tobacco Control Act; Issues related to tobacco smuggling; Issues related to the Affordable Care Act; Issues related to menthol cigarettes; Issues related to tobacco prevention; Issues related to youth cessation research; Issues related to nicotine; Issues related to health equity; Issues related to COVID-19 Response; Issues related to tobacco litter; Issues related to synthetic nicotine; Issues related to regulatory reform; Issues relating to the Presidents FY24 budget; Issues relating to FY25 appropriations; HR 277 REINS Act; S 184 REINS Act; S. 107 Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2023; HR 901 To require the Food and Drug Administration to prioritize enforcement of disposable electronic nicotine delivery system products; S. 464 No Tax Subsidies for E-Cigarette and Tobacco Ads; HR 2811 Limit Save Grow Act; HR 442 Regulatory Accountability Act; S 1615 Regulatory Accountability Act;; HR 288 Separation of Powers Restoration Act of 2023; HR 4368 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2024; S.2131 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2024; HR 4020 Children Don't Belong on Tobacco Farms Act; Issues related to Labor, Health and Human Services, Education and Related Agencies Appropriations Act, 2024; S 1411, Prove It Act of 2023; HR 4286 Increasing Access to Lung Cancer Screening Act; S 2213 Comprehensive Cancer Survivorship Act; HR 4363 Comprehensive Cancer Survivorship Act; HR 2398 To amend title 38, United States Code, to prohibit smoking on the premises of any facility of the Veterans Health Administration, and for other purposes.; S 1040 To amend title 38, United States Code, to prohibit smoking on the premises of any facility of the Veterans Health Administration, and for other purposes; S 2624 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2024; ; HR 890 The Guidance Out of Darkness Act; S 791 The Guidance Out of Darkness Act; HR 4775 Helping Tobacco Users Quit Act; HR 5894 Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2024, and for other purposes; S 3108 Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction Act; HR 6038 Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction Act Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction Act; HR 357 Ensuring Accountability in Agency Rulemaking; SJ Res 99 Exclude premium cigars from FDA oversight; ; HR 7463 Extension of Continuing Appropriations and Other Matters Act, 2024; HR 2872 Further Additional Continuing Appropriations and Other Extensions Act, 2024; HR4366 Consolidated Appropriations Act, 2024; HR 2882 Further Consolidated Appropriations Act, 2024; issues related to enforcement of illegal vaping;

Client expense: $220,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office

Helping Tobacco Users Quit Act (H.R. 4775, no bill number for Senate) Bipartisan Primary Care and Health Workforce Act (S. 2840; cuts to Prevention and Public Health Fund, which funds much of Office of Smoking and Health) Vetting and Patrolling E-Cigarette (VAPE) Imports Act (H.R. 7715, no bill number for Senate) Expressing the sense of the House of Representatives that public health authorities and tobacco control advocates should encourage American innovation and embrace harm reduction as part of the comprehensive United States approach to tobacco control. (H. R. 979) FDA action to remove menthol cigarettes from the market FDA action to remove flavored cigars from the market FDA regulation of synthetic nicotine FDA review of Premarket Tobacco Product applications FDA nicotine product standards

Client expense: $200,000 · Firm income: Not reported

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

Support banning the sale of menthol cigarettes and flavored cigars Oppose S 107: Traditional Cigar Manufacturing and Jobs Act Support HR 4775: Helping Tobacco Users Quit Act - provide coverage of comprehensive tobacco cessation services

Client expense: $150,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues relating to smoking cessation, age of sale of tobacco products, tobacco taxes, graphic warning labels, product regulation, and smoke-free environments, including: Implementation of the Family Smoking Prevention and Tobacco Control Act, including the FDA deeming regulation; Issues relating to FDA regulation of menthol, flavors, electronic cigarettes and cigars; The Quit Because of COVID-19 Act (Helping Tobacco Users Quit Act) The PROTECT Act Increasing Access to Lung Cancer Screening Act (H.R. 4286) Helping Tobacco Users Quit Act (H.R. 4775) Tobacco Tax Equity Act of 2023 (H.R. 5715/S. 2929)

Client expense: $2,670,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE, White House Office

Legislation and policies relating to: Adoption of recommendations of the National Academy of Medicine report, The Future of Nursing 2020-2030: Charting a Path to Achieve Health Equity Provisions of the Patient Protection & Affordable Care Act (P.L. 111-148) Reauthorization of the Childrens Health Insurance Program Reauthorization of the Child Nutrition Act Section 2706 of the ACA regarding provider non-discrimination Policies affecting nurse practitioner education and workforce Definition, evaluation and enforcement of essential health benefits and provider network adequacy Health information technology and electronic health records Mental health services and violence prevention H.R. 1147/S. 1957, Whole Milk for Healthy Kids Act of 2023 H.R. 1843/S.1001, Telehealth Expansion Act of 2023 H.R. 2411/S. 1150, National Nursing Workforce Centers Act of 2023 H.R. 2663/S. 1176, Workplace Violence Prevention for Health Care and Social Service Workers Act H.R. 2713/S. 2418, Improving Care and Access to Nurses (I CAN) Act H.R. 3073/S. 1452, Community Mental Wellness and Resilience Act of 2023 H.R 3226/S. 1573, PREEMIE Reauthorization Act of 2023 H.R. 3305/S. 1606, Black Maternal Health Momnibus Act H.R. 3331/S. 754, Improving Mental Health and Wellness in Schools Act H.R. 4531/S. 3393, SUPPORT for Patients and Communities Reauthorization Act of 2023 H.R.4775 - Helping Tobacco Users Quit Act H.R. 5378, Lower Costs, More Transparency Act H.R. 6122/S. 2853, Train More Nurses Act S.644/H.R. 1359, Modernizing Opioid Treatment Access Act S. 1409, Kids Online Safety Act S. 1418, Children and Teens Online Privacy Protection Act S. 1840/H.R. 3916, Screening for Communities to Receive Early and Equitable Needed Services (SCREENS) for Cancer Act of 2023 S. 2840, Bipartisan Primary Care and Health Workforce Act S. 3085, Preventing Adverse Childhood Experiences (PACE) Act

Client expense: Not reported · Firm income: $24,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Issues related to lung disease treatment, prevention and research; Issues related to tobacco cessation; Issues related to smokefree air; Issues related to the Tobacco Control Act; Issues related to tobacco smuggling; Issues related to the Affordable Care Act; Issues related to menthol cigarettes; Issues related to tobacco prevention; Issues related to youth cessation research; Issues related to nicotine; Issues related to health equity; Issues related to COVID-19 Response; Issues related to tobacco litter; Issues related to synthetic nicotine; Issues related to regulatory reform; Issues relating to the Presidents FY24 budget; Issues relating to FY24 appropriations; HR 277 REINS Act; S 184 REINS Act; S. 107 Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2023; HR 901 To require the Food and Drug Administration to prioritize enforcement of disposable electronic nicotine delivery system products; S. 464 No Tax Subsidies for E-Cigarette and Tobacco Ads; HR 2811 Limit Save Grow Act; HR 442 Regulatory Accountability Act; S 1615 Regulatory Accountability Act;; HR 288 Separation of Powers Restoration Act of 2023; HR 4368 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2024; S.2131 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2024; HR 4020 Children Don't Belong on Tobacco Farms Act; Issues related to Labor, Health and Human Services, Education and Related Agencies Appropriations Act, 2024; S 1411, Prove It Act of 2023; HR 4286 Increasing Access to Lung Cancer Screening Act; S 2213 Comprehensive Cancer Survivorship Act; HR 4363 Comprehensive Cancer Survivorship Act; HR 2398 To amend title 38, United States Code, to prohibit smoking on the premises of any facility of the Veterans Health Administration, and for other purposes.; S 1040 To amend title 38, United States Code, to prohibit smoking on the premises of any facility of the Veterans Health Administration, and for other purposes; S 2624 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2024; HR 4286 Increasing Access to Lung Cancer Screening Act; HR 890 The Guidance Out of Darkness Act; S 791 The Guidance Out of Darkness Act; HR 4775 Helping Tobacco Users Quit Act; HR 5894 Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2024, and for other purposes; S 3108 Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction Act; HR 6038 Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction Act Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction Act; HR 357 Ensuring Accountability in Agency Rulemaking; SJ Res 99 Exclude premium cigars from FDA oversight; HR 6363 Further Continuing Appropriations and Other Extensions Act, 2024

Client expense: $60,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office

Disposable ENDS Product Enforcement Act (H.R. 901) Helping Tobacco Users Quit Act (H.R. 4775/no bill number for Senate) Tobacco Tax Equity Act (H.R. 5715/S. 2929) Bipartisan Primary Care and Health Workforce Act (S. 2840; cuts to Prevention and Public Health Fund, which funds much of Office of Smoking and Health) FDA action to remove menthol cigarettes from the market FDA action to remove flavored cigars from the market FDA regulation of synthetic nicotine FDA review of Premarket Tobacco Product applications FDA nicotine product standards

Client expense: $170,000 · Firm income: Not reported

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

H.R. 4775, Helping Tobacco Users Quit Act, all provisions

Client expense: $5,740,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES

Lobbying Report: October 1 - December 31, 2023 (Campaign)     Federal (under tobacco issue code)   Legislation:   H.R. 4368/S. 2131- FY 24 Agriculture, Rural Developmental and Food and Drug Administration and Related Agencies Appropriations Bill   H.R. 5894/S. 2624 - FY 24 Labor, Health and Human Services, and Education, and Related Agencies Appropriations Bill   H.R. 901 - Disposable ENDS Product Enforcement Act of 2023   H.R. 4775 - Helping Tobacco Users Quit Act    H.J. Res. 99- Legislation to exempt certain cigars from FDA regulation  H.R. 6038/S. 3108 - Preventing Opportunities for Teen E-cigarette and Tobacco Addiction Act    S.2840 - Bipartisan Primary Care and Health Workforce Act (issues related to Prevention and Public Health Fund)      Issues   FDA proposed rule on menthol cigarettes    FDA proposed rule on flavored cigars   Prevention and Public Health Fund    FDA nicotine standard   Tobacco Cessation  FDA implementation of and enforcement of premarket review    CDC Reform  Tobacco User Fees  Graphic Warning Labels  FDA oversight of premium cigars    FDA enforcement of Tobacco Control Act   Enforcement against illegally imported tobacco products   Cigarettes and environmental pollution

Client expense: $80,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE

Issues relating to smoking cessation, age of sale of tobacco products, tobacco taxes, graphic warning labels, product regulation, and smoke-free environments, including: Implementation of the Family Smoking Prevention and Tobacco Control Act, including the FDA deeming regulation; Issues relating to FDA regulation of menthol, flavors, electronic cigarettes and cigars; The Quit Because of COVID-19 Act (Helping Tobacco Users Quit Act) The PROTECT Act Increasing Access to Lung Cancer Screening Act (H.R. 4286) Helping Tobacco Users Quit Act (H.R. 4775) Tobacco Tax Equity Act of 2023 (H.R. 5715/S. 2929)

Client expense: $3,030,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE, White House Office

Federal (under tobacco issue code) Legislation: H.R. 4368/S. 2131- FY 24 Agriculture, Rural Developmental and Food and Drug Administration and Related Agencies Appropriations Bill H.R. 5894/S. 2624 - FY 24 Labor, Health and Human Services, and Education, and Related Agencies Appropriations Bill H.R. 901 - Disposable ENDS Product Enforcement Act of 2023 H.R. 4775 - Helping Tobacco Users Quit Act H.J. Res. 99- Legislation to exempt certain cigars from FDA regulation H.R. 6038/S. 3108 - Preventing Opportunities for Teen E-cigarette and Tobacco Addiction Act S.2840 - Bipartisan Primary Care and Health Workforce Act (issues related to Prevention and Public Health Fund) Issues FDA proposed rule on menthol cigarettes FDA proposed rule on flavored cigars Prevention and Public Health Fund FDA nicotine standard Tobacco Cessation FDA implementation of and enforcement of premarket review CDC Reform Tobacco User Fees Graphic Warning Labels FDA oversight of premium cigars FDA enforcement of Tobacco Control Act Enforcement against illegally imported tobacco products Cigarettes and environmental pollution Agencies Visited: Centers for Disease Control and Prevention US House of Representatives US Senate Food and Drug administration OMB

Client expense: $430,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE

Advancing Safe Medications for Moms and Babies Act (H.R. 1117) SHINE for Autumn Act Maternal and Child Health Stillbirth Prevention Act (S.2231/H.R. 4581) Vaccination policy PREEMIE Reauthorization Act of 2023 (S.1573 /H.R.3226) Preventing Maternal Deaths Act Reauthorization of 2023 (S. 2415/H.R. 3838) Black Maternal Health Momnibus Act (S. 1606/H.R. 3305) Advancing Maternal Health Equity Under Medicaid Act (H.R. 6612) Midwives for MOMS Act of 2023 (S. 1851/H.R. 3768) Stop Shackling and Detaining Pregnant Women Act (S.2128/H.R.3993) Delivering Optimally Urgent Labor Access for Veterans Affairs Act of 2023 (DOULA Act) (S.2465) Supporting Healthy Mothers and Infants Act (H.R.5312) Child Care Assistance for Maternal Health Act (H.R. 5581) Access to Donor Milk Act (S. 2819/H.R. 5486) Safeguarding Kids and Families from Critical Food Shortages Act (H.R. 5316) The Helping Tobacco Users Quit Act (H.R. 4775) Maximizing Outcomes for Moms through Medicaid Improvement and Enhancement of Services (MOMMIES) Act (S. 3090) Support Through Loss Act (S.3137/H.R.6103) Delivering Optimally Urgent Labor Access for Veterans Affairs Act (DOULA Act) (S.2465/H.R.6331) House Prematurity Awareness Month resolution (H. Res. 874) Promoting Maternal and Child Health Through Substance Use Prevention Act (S.3370) Healthy MOM Act (S. 3509/H.R. 6716)

Client expense: $30,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE

Support banning the sale of menthol cigarettes and flavored cigars Oppose S 107: Traditional Cigar Manufacturing and Jobs Act Support HR 4775: Helping Tobacco Users Quit Act - provide coverage of comprehensive tobacco cessation services

Client expense: $130,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Abortion access (general); Access to Mifepristone (general); Contraception (general); Maternal Mortality and Morbidity (general); H.R. 1117, Advancing Safe Medications for Moms and Babies Act; obstetric and gynecologic care in rural areas (general; H.R. 3305/S. 1606, Black Maternal Health Momnibus Act; H.R. 952, Kids Access to Primary Care Act of 2023; H.R. 1202/S. 704, Resident Education Deferred Interest (REDI) Act; H.R. 4933/S. 462, Mental Health Professionals Workforce Shortage Loan Repayment Act of 2023; H.R. 2389/S. 1302, Resident Physician Shortage Reduction Act of 2023; H.R. 2569, Doctors of Community (DOC) Act; Teaching Health Center Graduate Medication Education (general); physician workforce and training (general); H.R. 3838/S. 2415, Preventing Maternal Deaths Reauthorization Act of 2023; H.R. 3226/S. 1573, PREEMIE Reauthorization Act of 2023; inclusion of pregnant and lactating individuals in research (general); Implementation of P.L. 115-320, Improving Access to Maternity Care Act; telemedicine (general); H.R. 5012/S. 2647, SHINE for Autumn Act; Rural Residency Planning and Development (RRPD) Program; H.R. 4581/S. 2231, Maternal and Child Health Stillbirth Prevention Act; Implementation of P.L. 117-328, Consolidated Appropriations Act, including the Pregnant Workers Fairness Act; Health Insurance Portability and Accountability Act (general); patient-physician relationship (general); H.R. 4605/S. 948, Healthy Moms and Babies Act; H.R. 4816/S. 2427, Convenient Contraception Act; Cost-sharing for maternity care (general); H.R. 4796/S. 2439, Reproductive Health Patient Navigator Act; H.R. 4731/S. 2386, Access to Infertility Treatment and Care Act; H.R. 5066, Tech to Save Moms Act; H.R. 4901/S. 2544, Reproductive Health Care Accessibility Act; Conscientious refusals in medicine (general); H.R. 834/S. 230, Rural Physician Workforce Production Act; menopause research (general); Alliance for Innovation on Maternal Health; Residency programs in obstetrics and gynecology (general); H.R. 5568/S. 2846, CARE for Moms Act; Value-based care models for obstetrics and gynecology (general); S. 3006, SAFE in Recovery Act; H.R. 4775, Helping Tobacco Users Quit Act; Treatment of reproductive health information under the Stored Communications Act (general); Congenital syphilis (general); Tax treatment of stillbirths (general); Substance use disorder during pregnancy (general); H.R. 117, NEWBORN Act; Physician burnout (general); Maternal mental health (general).

Client expense: $130,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Equal Employment Opportunity Commission (EEOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE, White House Office

Abortion access (general); Access to Mifepristone (general); Contraception (general); Maternal Mortality and Morbidity (general); H.R. 1117, Advancing Safe Medications for Moms and Babies Act; obstetric and gynecologic care in rural areas (general; H.R. 3305/S. 1606, Black Maternal Health Momnibus Act; H.R. 952, Kids Access to Primary Care Act of 2023; H.R. 1202/S. 704, Resident Education Deferred Interest (REDI) Act; H.R. 4933/S. 462, Mental Health Professionals Workforce Shortage Loan Repayment Act of 2023; H.R. 2389/S. 1302, Resident Physician Shortage Reduction Act of 2023; H.R. 2569, Doctors of Community (DOC) Act; Teaching Health Center Graduate Medication Education (general); physician workforce and training (general); H.R. 3838/S. 2415, Preventing Maternal Deaths Reauthorization Act of 2023; H.R. 3226/S. 1573, PREEMIE Reauthorization Act of 2023; inclusion of pregnant and lactating individuals in research (general); Implementation of P.L. 115-320, Improving Access to Maternity Care Act; telemedicine (general); H.R. 5012/S. 2647, SHINE for Autumn Act; Rural Residency Planning and Development (RRPD) Program; H.R. 4581/S. 2231, Maternal and Child Health Stillbirth Prevention Act; Implementation of P.L. 117-328, Consolidated Appropriations Act, including the Pregnant Workers Fairness Act; Health Insurance Portability and Accountability Act (general); patient-physician relationship (general); H.R. 4605/S. 948, Healthy Moms and Babies Act; H.R. 4816/S. 2427, Convenient Contraception Act; Cost-sharing for maternity care (general); H.R. 4796/S. 2439, Reproductive Health Patient Navigator Act; H.R. 4731/S. 2386, Access to Infertility Treatment and Care Act; H.R. 5066, Tech to Save Moms Act; H.R. 4901/S. 2544, Reproductive Health Care Accessibility Act; Conscientious refusals in medicine (general); H.R. 834/S. 230, Rural Physician Workforce Production Act; menopause research (general); Alliance for Innovation on Maternal Health; Residency programs in obstetrics and gynecology (general); H.R. 5568/S. 2846, CARE for Moms Act; Value-based care models for obstetrics and gynecology (general); S. 3006, SAFE in Recovery Act; H.R. 4775, Helping Tobacco Users Quit Act; Treatment of reproductive health information under the Stored Communications Act (general); Congenital syphilis (general); Tax treatment of stillbirths (general); Substance use disorder during pregnancy (general); H.R. 117, NEWBORN Act; Physician burnout (general); Maternal mental health (general).

Client expense: $130,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Equal Employment Opportunity Commission (EEOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE, White House Office

Abortion access (general); Access to Mifepristone (general); Contraception (general); Maternal Mortality and Morbidity (general); H.R. 1117, Advancing Safe Medications for Moms and Babies Act; obstetric and gynecologic care in rural areas (general; H.R. 3305/S. 1606, Black Maternal Health Momnibus Act; H.R. 952, Kids Access to Primary Care Act of 2023; H.R. 1202/S. 704, Resident Education Deferred Interest (REDI) Act; H.R. 4933/S. 462, Mental Health Professionals Workforce Shortage Loan Repayment Act of 2023; H.R. 2389/S. 1302, Resident Physician Shortage Reduction Act of 2023; H.R. 2569, Doctors of Community (DOC) Act; Teaching Health Center Graduate Medication Education (general); physician workforce and training (general); H.R. 3838/S. 2415, Preventing Maternal Deaths Reauthorization Act of 2023; H.R. 3226/S. 1573, PREEMIE Reauthorization Act of 2023; inclusion of pregnant and lactating individuals in research (general); Implementation of P.L. 115-320, Improving Access to Maternity Care Act; telemedicine (general); H.R. 5012/S. 2647, SHINE for Autumn Act; Rural Residency Planning and Development (RRPD) Program; H.R. 4581/S. 2231, Maternal and Child Health Stillbirth Prevention Act; Implementation of P.L. 117-328, Consolidated Appropriations Act, including the Pregnant Workers Fairness Act; Health Insurance Portability and Accountability Act (general); patient-physician relationship (general); H.R. 4605/S. 948, Healthy Moms and Babies Act; H.R. 4816/S. 2427, Convenient Contraception Act; Cost-sharing for maternity care (general); H.R. 4796/S. 2439, Reproductive Health Patient Navigator Act; H.R. 4731/S. 2386, Access to Infertility Treatment and Care Act; H.R. 5066, Tech to Save Moms Act; H.R. 4901/S. 2544, Reproductive Health Care Accessibility Act; Conscientious refusals in medicine (general); H.R. 834/S. 230, Rural Physician Workforce Production Act; menopause research (general); Alliance for Innovation on Maternal Health; Residency programs in obstetrics and gynecology (general); H.R. 5568/S. 2846, CARE for Moms Act; Value-based care models for obstetrics and gynecology (general); S. 3006, SAFE in Recovery Act; H.R. 4775, Helping Tobacco Users Quit Act; Treatment of reproductive health information under the Stored Communications Act (general); Congenital syphilis (general); Tax treatment of stillbirths (general); Substance use disorder during pregnancy (general); H.R. 117, NEWBORN Act; Physician burnout (general); Maternal mental health (general).

Client expense: $130,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Equal Employment Opportunity Commission (EEOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE, White House Office

E-Cigarettes, H.R.4775 - Helping Tobacco Users Quit Act, H.R.4366 - Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2024

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Lobbying Report: July 1 - September 30, 2023 (Action Fund) Federal (under tobacco issue code) Legislation: H.R. 4368/S. 2131 - FY 24 Agriculture, Rural Developmental and Food and Drug Administration and Related Agencies Appropriations Bill S. 2624 - FY 24 Labor , Health and Human Services, and Education, and Related Agencies Appropriations Bill H.R. 901 - Disposable ENDS Product Enforcement Act of 2023 H.R. 4775 - Helping Tobacco Users Quit Act END ENDS Act S. 1040 - Smokefree Veterans Health Administration S.2840 - Bipartisan Primary Care and Health Workforce Act H.R. 5378 - Lower Costs, More Transparency Act Preventing Opportunities for Teen E-cigarette and Tobacco Addiction Act Prevention Fund H.R. 5715/S.2929 - Tobacco Tax Equity Act Health Equity and Accountability Act S. 2438/H.R. 4665 - FY 24 Department of State, Foreign Operations, and Related Programs Appropriations Act Issues FDA proposed rule on menthol cigarettes FDA proposed rule on flavored cigars Prevention and Public Health Fund Nicotine Pouches FDA nicotine standard Tobacco CessationFDA implementation of and enforcement of premarket review Nicotine poisonings from e-cigarettes FDAs strategic plan Congressional Caucus to End the Youth Vaping Epidemic FDA oversight of premium cigars FDA implementation of Tobacco Control Act and hiring authority VA and Tobacco Cancer Moonshot E-cigarette Tax Lung Cancer Screening Labeling Cigarette Filter Waste Agencies Visited: Centers for Disease Control and Prevention US House of Representatives US Senate Food and Drug Administration OMB

Client expense: $420,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE

Lobbying Report: July 1 - September 30, 2023 (Campaign) Federal (under tobacco issue code) Legislation: H.R. 4368/S. 2131- FY 24 Agriculture, Rural Developmental and Food and Drug Administration and Related Agencies Appropriations Bill S. 2624 - FY 24 Labor, Health and Human Services, and Education, and Related Agencies Appropriations Bill H.R. 901 - Disposable ENDS Product Enforcement Act of 2023 H.R. 4775 - Helping Tobacco Users Quit Act END ENDS Act S. 1040 - Smokefree Veterans Health Administration S.2840 - Bipartisan Primary Care and Health Workforce Act H.R. 5378 - Lower Costs, More Transparency Act Preventing Opportunities for Teen E-cigarette and Tobacco Addiction Act Prevention Fund H.R. 5715/S.2929 - Tobacco Tax Equity Act Health Equity and Accountability Act S. 2438/H.R. 4665 - FY 24 Department of State, Foreign Operations, and Related Programs Appropriations Act Issues FDA proposed rule on menthol cigarettes FDA proposed rule on flavored cigars Prevention and Public Health Fund Nicotine Pouches FDA nicotine standard Tobacco Cessation FDA implementation of and enforcement of premarket review Nicotine poisonings from e-cigarettes FDAs strategic plan Congressional Caucus to End the Youth Vaping Epidemic FDA oversight of premium cigars FDA implementation of Tobacco Control Act and hiring authority VA and Tobacco Cancer Moonshot E-cigarette Tax Lung Cancer Screening Labeling Cigarette Filter Waste Agencies Visited: Centers for Disease Control and Prevention US House of Representatives US Senate Food and Drug Administration OMB

Client expense: $193,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE

Abortion access (general); Access to Mifepristone (general); Contraception (general); Maternal Mortality and Morbidity (general); H.R. 1117, Advancing Safe Medications for Moms and Babies Act; obstetric and gynecologic care in rural areas (general; H.R. 3305/S. 1606, Black Maternal Health Momnibus Act; H.R. 952, Kids Access to Primary Care Act of 2023; H.R. 1202/S. 704, Resident Education Deferred Interest (REDI) Act; H.R. 4933/S. 462, Mental Health Professionals Workforce Shortage Loan Repayment Act of 2023; H.R. 2389/S. 1302, Resident Physician Shortage Reduction Act of 2023; H.R. 2569, Doctors of Community (DOC) Act; Teaching Health Center Graduate Medication Education (general); physician workforce and training (general); H.R. 3838/S. 2415, Preventing Maternal Deaths Reauthorization Act of 2023; H.R. 3226/S. 1573, PREEMIE Reauthorization Act of 2023; inclusion of pregnant and lactating individuals in research (general); Implementation of P.L. 115-320, Improving Access to Maternity Care Act; telemedicine (general); H.R. 5012/S. 2647, SHINE for Autumn Act; Rural Residency Planning and Development (RRPD) Program; H.R. 4581/S. 2231, Maternal and Child Health Stillbirth Prevention Act; Implementation of P.L. 117-328, Consolidated Appropriations Act, including the Pregnant Workers Fairness Act; Health Insurance Portability and Accountability Act (general); patient-physician relationship (general); H.R. 4605/S. 948, Healthy Moms and Babies Act; H.R. 4816/S. 2427, Convenient Contraception Act; Cost-sharing for maternity care (general); H.R. 4796/S. 2439, Reproductive Health Patient Navigator Act; H.R. 4731/S. 2386, Access to Infertility Treatment and Care Act; H.R. 5066, Tech to Save Moms Act; H.R. 4901/S. 2544, Reproductive Health Care Accessibility Act; Conscientious refusals in medicine (general); H.R. 834/S. 230, Rural Physician Workforce Production Act; menopause research (general); Alliance for Innovation on Maternal Health; Residency programs in obstetrics and gynecology (general); H.R. 5568/S. 2846, CARE for Moms Act; Value-based care models for obstetrics and gynecology (general); S. 3006, SAFE in Recovery Act; H.R. 4775, Helping Tobacco Users Quit Act; Treatment of reproductive health information under the Stored Communications Act (general); Congenital syphilis (general); Tax treatment of stillbirths (general); Substance use disorder during pregnancy (general); H.R. 117, NEWBORN Act; Physician burnout (general); Maternal mental health (general).

Client expense: $130,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Equal Employment Opportunity Commission (EEOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE, White House Office

Reauthorization of the Pandemic and All-Hazards Preparedness Act Preventing Maternal Deaths Reauthorization Act of 2023 Public Health Loan Repayment Program Bio-Preparedness Workforce Pilot Program Support of Rules to Prohibit Menthol Cigarettes and Flavored Cigars Helping Tobacco Users to Quit (H.R. 4775) State Medical Stockpiles (as authorized in H.R. 2617) Maternal and Child Health Stillbirth Prevention Act (H.R. 4581) Hospitals as Naloxone Distribution Sites Bill (H.R. 5506) Concentrating on High-Value Alzheimer's Needs to Get to an End (CHANGE) Act (H.R. 4752) Safe Response Act (H.R. 4089) Prevention and Public Health Fund Drinking Water State Revolving Fund Conrad 30 Waiver Program

Client expense: $90,331 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Disposable ENDS Product Enforcement Act (H.R. 901) Helping Tobacco Users Quit Act (H.R. 4775/no bill number for Senate) Tobacco Tax Equity Act (H.R. 5715/S. 2929) Bipartisan Primary Care and Health Workforce Act (S. 2840; cuts to Prevention and Public Health Fund, which funds much of Office of Smoking and Health) FDA action to remove menthol cigarettes from the market FDA action to remove flavored cigars from the market FDA regulation of synthetic nicotine FDA review of Modified Risk Tobacco Product applications FDA review of Premarket Tobacco Product applications FDA nicotine product standards

Client expense: $130,000 · Firm income: Not reported

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

September 28, 2023 coalition letter to Representative Lisa Blunt Rochester and Representative Brian Fitzpatrick in support of H.R. 4775, the Helping Tobacco Users Quit Act, that will ensure that all Medicaid and Childrens Health Insurance Program enrollees have access to the full array of evidence-based tobacco cessation treatments, including all Food and Drug Administration medications. Issues pertaining to tobacco control, in general.

Client expense: $280,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

August 17, 2023 letter to CMS Administrator Chiquita Brooks-LaSure in response to the agency's Request for Information on Episode-Based Payment Models expressing support for the agency's broad goal of providing enhanced patient care in the context of value-based reimbursement arrangements. August 30, 2023 comment letter regarding the Food and Drug Administration's Center for Devices and Radiological Healths (CDRH) search for input from the physician community on advancing health equity and facilitating access to medical devices designed to be safe and effective when used outside of traditional clinical settings such as the home setting. September 11, 2023 letter to CMS Administrator Chiquita Brooks-LaSure in response to the calendar year 2024 Medicare Physician Fee Schedule and Quality Payment Program proposed rule. September 11, 2023 letter to CMS Administrator Chiquita Brooks-LaSure pertaining to the ambulatory surgical center payment update and updated APC classifications for various HCPCS codes. September 28, 2023 coalition letter to Representative Lisa Blunt Rochester and Representative Brian Fitzpatrick in support of H.R. 4775, the Helping Tobacco Users Quit Act, that will ensure that all Medicaid and Childrens Health Insurance Program enrollees have access to the full array of evidence-based tobacco cessation treatments, including all Food and Drug Administration medications. Issues pertaining to scope of practice legislation specifically related to opposition of S. 2377, the Medicare Audiology Access Improvement Act of 2023, and in general. Issues related to the support of the Safe Step Act (S. 652 / H.R. 2630) which would improve patient access by requiring insurance providers to implement a clear and transparent process for a patient or physician to request an exception to a step therapy protocol. Issues pertaining to prior authorization, in general. Issues pertaining to Medicare physician reimbursement related to H.R. 2474, the Strengthening Medicare for Patients and Providers Act, and in general. Issues related to hearing healthcare, in general. Issues pertaining to the implementation of the No Surprises Act. Issues pertaining to health information technology and electronic health records, in general. Issues pertaining to Graduate Medical Education, in general. Issues pertaining to healthcare liability reform, in general. Issues pertaining to healthcare practice and the Federal Supremacy Clause at the Department of Veterans Affairs, in general.

Client expense: $280,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE

August 17, 2023 letter to CMS Administrator Chiquita Brooks-LaSure in response to the agency's Request for Information on Episode-Based Payment Models expressing support for the agency's broad goal of providing enhanced patient care in the context of value-based reimbursement arrangements. September 11, 2023 letter to CMS Administrator Chiquita Brooks-LaSure in response to the calendar year 2024 Medicare Physician Fee Schedule and Quality Payment Program proposed rule. September 11, 2023 letter to CMS Administrator Chiquita Brooks-LaSure pertaining to the ambulatory surgical center payment update and updated APC classifications for various HCPCS codes. September 28, 2023 coalition letter to Representative Lisa Blunt Rochester and Representative Brian Fitzpatrick in support of H.R. 4775, the Helping Tobacco Users Quit Act, that will ensure that all Medicaid and Childrens Health Insurance Program enrollees have access to the full array of evidence-based tobacco cessation treatments, including all Food and Drug Administration medications. Issues pertaining to scope of practice legislation specifically related to opposition of S. 2377, the Medicare Audiology Access Improvement Act of 2023, and in general. Issues pertaining to prior authorization, in general. Issues pertaining to Medicare physician reimbursement, related to H.R. 2474, the Strengthening Medicare for Patients and Providers Act, and in general. Issues related to hearing healthcare, in general. Issues pertaining to health information technology and electronic health records, in general.

Client expense: $280,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

Issues relating to smoking cessation, age of sale of tobacco products, tobacco taxes, graphic warning labels, product regulation, and smoke-free environments, including: Implementation of the Family Smoking Prevention and Tobacco Control Act, including the FDA deeming regulation; Issues relating to FDA regulation of menthol, flavors, electronic cigarettes and cigars; The Quit Because of COVID-19 Act (Helping Tobacco Users Quit Act) The PROTECT Act Increasing Access to Lung Cancer Screening Act (H.R. 4286) Helping Tobacco Users Quit Act (H.R. 4775) Tobacco Tax Equity Act of 2023 (H.R. 5715/S. 2929)

Client expense: $2,060,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, White House Office

Advancing Safe Medications for Moms and Babies Act (H.R. 1117) SHINE for Autumn Act Maternal and Child Health Stillbirth Prevention Act (S.2231/H.R. 4581) Vaccination policy PREEMIE Reauthorization Act of 2023 (S.1573 /H.R.3226) Preventing Maternal Deaths Act Reauthorization of 2023 (S. 2415/H.R. 3838) Black Maternal Health Momnibus Act (S. 1606/H.R. 3305) Advancing Maternal Health Equity Under Medicaid Act (H.R. 6612) Midwives for MOMS Act of 2023 (S. 1851/H.R. 3768) Stop Shackling and Detaining Pregnant Women Act (S.2128/H.R.3993) Delivering Optimally Urgent Labor Access for Veterans Affairs Act of 2023 (DOULA Act) (S.2465) Supporting Healthy Mothers and Infants Act (H.R.5312) Child Care Assistance for Maternal Health Act (H.R. 5581) Access to Donor Milk Act (S. 2819/H.R. 5486) Safeguarding Kids and Families from Critical Food Shortages Act (H.R. 5316) The Helping Tobacco Users Quit Act (H.R. 4775)

Client expense: $50,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE

Issues related to lung disease treatment, prevention and research; Issues related to tobacco cessation; Issues related to smokefree air; Issues related to the Tobacco Control Act; Issues related to tobacco smuggling; Issues related to the Affordable Care Act; Issues related to menthol cigarettes; Issues related to tobacco prevention; Issues related to youth cessation research; Issues related to nicotine; Issues related to health equity; Issues related to COVID-19 Response; Issues related to tobacco litter; Issues related to synthetic nicotine; Issues related to regulatory reform; Issues relating to the Presidents FY24 budget; Issues relating to FY24 appropriations; HR 277 REINS Act; S 184 REINS Act; S. 107 Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2023; HR 901 To require the Food and Drug Administration to prioritize enforcement of disposable electronic nicotine delivery system products; S. 464 No Tax Subsidies for E-Cigarette and Tobacco Ads; HR 2811 Limit Save Grow Act; HR 442 Regulatory Accountability Act; S 1615 Regulatory Accountability Act;; HR 288 Separation of Powers Restoration Act of 2023; HR 4368 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2024; S.2131 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2024; HR 4020 Children Don't Belong on Tobacco Farms Act; Issues related to Labor, Health and Human Services, Education and Related Agencies Appropriations Act, 2024; S 1411, Prove It Act of 2023; HR 4286 Increasing Access to Lung Cancer Screening Act; S 2213 Comprehensive Cancer Survivorship Act; HR 4363 Comprehensive Cancer Survivorship Act; HR 2398 To amend title 38, United States Code, to prohibit smoking on the premises of any facility of the Veterans Health Administration, and for other purposes.; S 1040 To amend title 38, United States Code, to prohibit smoking on the premises of any facility of the Veterans Health Administration, and for other purposes; S 2624 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2024; HR 5525 Continuing Appropriations and Border Security Enhancement Act, 2024; HR 2860 Continuing Appropriations Act, 2024 and Other Extensions Act; HR 4286 Increasing Access to Lung Cancer Screening Act; HR 890 The Guidance Out of Darkness Act; S 791 The Guidance Out of Darkness Act; HR 4775 Helping Tobacco Users Quit Act

Client expense: $60,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE, White House Office

Pandemic All Hazards Preparedness Act reauthorization CDC Funding in FY2024 Labor, Health and Human Services bill, including immunization, smoking and health, social determinants of health, violence prevention, public health preparedness, epi and lab capacity, Data Modernization Initiative, Center for Forecasting Outbreak and Analytics, climate and health, overdose prevention, public health workforce, capacity and infrastructure, infectious diseases HHS Funding for Title X and Teen Pregnancy Prevention Program Overdose prevention, Modernizing Opioid Treatment Access Act (HR 1359/S 644) Regulation of Tobacco/Nicotine and flavors Preventing Overdoses with Test Strips Act (S.2976) Helping Tobacco Users Quit Act (H.R. 4775) Safe Response Act (H.R. 4089/S.2933)

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Support banning the sale of menthol cigarettes and flavored cigars Oppose S 107: Traditional Cigar Manufacturing and Jobs Act Support HR 4775: Helping Tobacco Users Quit Act - provide coverage of comprehensive tobacco cessation services

Client expense: $100,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Advocated for increased FY24 funding for HRSA's Addiction Medicine Fellowship Program ($30M) Advocated for increased FY24 funding for HRSA's Substance Use Disorder Treatment and Recovery Loan Repayment Program ($50M) Advocated for (S. 644/H.R. 1359) the Modernizing Opioid Treatment Access Act, which would allow specially registered opioid treatment program clinicians and addiction specialist physicians to prescribe methadone for OUD that can be picked up from pharmacies, subject to federal regulation or guidance on supply of methadone for unsupervised use. Advocated for S. 1165/ HR 2400- the Reentry Act, which would allow states to provide Medicaid coverage to eligible individuals up to 30 days prior to release from incarceration Advocated for HR 3074/S.971 - Due Process Continuity of Care Act, which would amend title XIX of the Social Security Act to remove the Medicaid coverage exclusion for inmates in custody pending disposition of charges, and for other purposes. Worked on draft legislation that would provide Medicare coverage for evidence-based residential SUD services Supported H.R.1502 - Comprehensive Opioid Recovery Centers Reauthorization Act of 2023, in its entirety Advocated for removal of in-person evaluation requirement in proposed telemedicine rules by the DEA and worked on related draft legislation Opposed proposed changes to the STAR-LRP program in S.462 - the Mental Health Professionals Workforce Shortage Loan Repayment Act of 2023 Advocated for removal of a lifetime ban that prevents individuals convicted of a drug felony from receiving Supplemental Nutritional Assistance Program (SNAP) or Temporary Assistance for Needy Families TANF) as part of the next Farm Bill. Advocated for various substance use disorder workforce and coverage policy changes, including some of which appear in H.R. 4531, the Support for Patients and Communities Reauthorization Act. Advocated for certain annual increases for Medicare office based SUD bundled codes. ASAM signed a letter in support of S. 1378, Connecting Our Medical Providers with Links to Expand Tailored and Effective Act (the "COMPLETE Act"), which would advance collaborative care models. ASAM signed a letter sent by a broad coalition of health care clinicians, patient advocates, and other stakeholders, urging Congressional leaders to support the Centers for Medicare and Medicaid Services' (CMS) proposal to implement a Medicare billing code, known as G2211, in 2024. ASAM submitted comments to the Centers for Medicare and Medicaid Services (CMS) on the proposed 2024 MPFS and OPPS rules, encouraging CMS to finalize many new Medicare proposals, with several modifications. ASAM joined several other organizations in a letter to the leadership of the House Committee on Oversight and Accountability opposing the U.S. Shipping Equity Act (H.R. 3721) that would allow the U.S. Post Office (USPS) to ship beverage alcohol. ASAM signed a letter supporting the Helping Tobacco Users Quit Act (H.R. 4775), which would ensure Medicaid and Childrens Health Insurance Program (CHIP) enrollees have access to all evidence-based tobacco cessation treatments, including seven Food and Drug Administration-approved medications. Advocated for DEA related clarifications or changes to registration requirements related to the delivery of injectable buprenorphine. Supported S 2919 - Advancing Lifesaving Efforts with Rapid Test Strips for Communities Act (ALERT Communities Act) to help expand access to fentanyl and xylazine test strips, a critical tool to help lower overdose deaths. Supported HR 5506 - Hospitals As Naloxone Distribution Sites (HANDS) Act, which would require Medicare, Medicaid, and TRICARE to cover the cost when medical providers physically hand naloxone to patients who are at risk of an overdose, before they are discharged, at zero cost to the patient. Supported H.R.5163 - Telehealth Response for E-prescribing Addiction Therapy Services Act, which would amend the Controlled Substances Act to allow for the use of telehealth in substance use disorder treatment. Supported S.3006 - SAFE in Recovery Act, which would ensure comprehensive wraparound services for families impacted by substance use disorders. Advocated for reforms to the Child Abuse Prevention and Treatment Act related to pregnant women who take medications for substance use disorder. Advocated for continued telemedicine flexibilities related to medications for substance use disorder.

Client expense: $40,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Natl Drug Control Policy (NDCP), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)

Advocated for increased FY24 funding for HRSA's Addiction Medicine Fellowship Program ($30M) Advocated for increased FY24 funding for HRSA's Substance Use Disorder Treatment and Recovery Loan Repayment Program ($50M) Advocated for (S. 644/H.R. 1359) the Modernizing Opioid Treatment Access Act, which would allow specially registered opioid treatment program clinicians and addiction specialist physicians to prescribe methadone for OUD that can be picked up from pharmacies, subject to federal regulation or guidance on supply of methadone for unsupervised use. Advocated for S. 1165/ HR 2400- the Reentry Act, which would allow states to provide Medicaid coverage to eligible individuals up to 30 days prior to release from incarceration Advocated for HR 3074/S.971 - Due Process Continuity of Care Act, which would amend title XIX of the Social Security Act to remove the Medicaid coverage exclusion for inmates in custody pending disposition of charges, and for other purposes. Worked on draft legislation that would provide Medicare coverage for evidence-based residential SUD services Supported H.R.1502 - Comprehensive Opioid Recovery Centers Reauthorization Act of 2023, in its entirety Advocated for removal of in-person evaluation requirement in proposed telemedicine rules by the DEA and worked on related draft legislation Opposed proposed changes to the STAR-LRP program in S.462 - the Mental Health Professionals Workforce Shortage Loan Repayment Act of 2023 Advocated for removal of a lifetime ban that prevents individuals convicted of a drug felony from receiving Supplemental Nutritional Assistance Program (SNAP) or Temporary Assistance for Needy Families TANF) as part of the next Farm Bill. Advocated for various substance use disorder workforce and coverage policy changes, including some of which appear in H.R. 4531, the Support for Patients and Communities Reauthorization Act. Advocated for certain annual increases for Medicare office based SUD bundled codes. ASAM signed a letter in support of S. 1378, Connecting Our Medical Providers with Links to Expand Tailored and Effective Act (the "COMPLETE Act"), which would advance collaborative care models. ASAM signed a letter sent by a broad coalition of health care clinicians, patient advocates, and other stakeholders, urging Congressional leaders to support the Centers for Medicare and Medicaid Services' (CMS) proposal to implement a Medicare billing code, known as G2211, in 2024. ASAM submitted comments to the Centers for Medicare and Medicaid Services (CMS) on the proposed 2024 MPFS and OPPS rules, encouraging CMS to finalize many new Medicare proposals, with several modifications. ASAM joined several other organizations in a letter to the leadership of the House Committee on Oversight and Accountability opposing the U.S. Shipping Equity Act (H.R. 3721) that would allow the U.S. Post Office (USPS) to ship beverage alcohol. ASAM signed a letter supporting the Helping Tobacco Users Quit Act (H.R. 4775), which would ensure Medicaid and Childrens Health Insurance Program (CHIP) enrollees have access to all evidence-based tobacco cessation treatments, including seven Food and Drug Administration-approved medications. Advocated for DEA related clarifications or changes to registration requirements related to the delivery of injectable buprenorphine. Supported S 2919 - Advancing Lifesaving Efforts with Rapid Test Strips for Communities Act (ALERT Communities Act) to help expand access to fentanyl and xylazine test strips, a critical tool to help lower overdose deaths. Supported HR 5506 - Hospitals As Naloxone Distribution Sites (HANDS) Act, which would require Medicare, Medicaid, and TRICARE to cover the cost when medical providers physically hand naloxone to patients who are at risk of an overdose, before they are discharged, at zero cost to the patient. Supported H.R.5163 - Telehealth Response for E-prescribing Addiction Therapy Services Act, which would amend the Controlled Substances Act to allow for the use of telehealth in substance use disorder treatment. Supported S.3006 - SAFE in Recovery Act, which would ensure comprehensive wraparound services for families impacted by substance use disorders. Advocated for reforms to the Child Abuse Prevention and Treatment Act related to pregnant women who take medications for substance use disorder. Advocated for continued telemedicine flexibilities related to medications for substance use disorder.

Client expense: $40,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Natl Drug Control Policy (NDCP), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)

Advocated for increased FY24 funding for HRSA's Addiction Medicine Fellowship Program ($30M) Advocated for increased FY24 funding for HRSA's Substance Use Disorder Treatment and Recovery Loan Repayment Program ($50M) Advocated for (S. 644/H.R. 1359) the Modernizing Opioid Treatment Access Act, which would allow specially registered opioid treatment program clinicians and addiction specialist physicians to prescribe methadone for OUD that can be picked up from pharmacies, subject to federal regulation or guidance on supply of methadone for unsupervised use. Advocated for S. 1165/ HR 2400- the Reentry Act, which would allow states to provide Medicaid coverage to eligible individuals up to 30 days prior to release from incarceration Advocated for HR 3074/S.971 - Due Process Continuity of Care Act, which would amend title XIX of the Social Security Act to remove the Medicaid coverage exclusion for inmates in custody pending disposition of charges, and for other purposes. Worked on draft legislation that would provide Medicare coverage for evidence-based residential SUD services Supported H.R.1502 - Comprehensive Opioid Recovery Centers Reauthorization Act of 2023, in its entirety Advocated for removal of in-person evaluation requirement in proposed telemedicine rules by the DEA and worked on related draft legislation Opposed proposed changes to the STAR-LRP program in S.462 - the Mental Health Professionals Workforce Shortage Loan Repayment Act of 2023 Advocated for removal of a lifetime ban that prevents individuals convicted of a drug felony from receiving Supplemental Nutritional Assistance Program (SNAP) or Temporary Assistance for Needy Families TANF) as part of the next Farm Bill. Advocated for various substance use disorder workforce and coverage policy changes, including some of which appear in H.R. 4531, the Support for Patients and Communities Reauthorization Act. Advocated for certain annual increases for Medicare office based SUD bundled codes. ASAM signed a letter in support of S. 1378, Connecting Our Medical Providers with Links to Expand Tailored and Effective Act (the "COMPLETE Act"), which would advance collaborative care models. ASAM signed a letter sent by a broad coalition of health care clinicians, patient advocates, and other stakeholders, urging Congressional leaders to support the Centers for Medicare and Medicaid Services' (CMS) proposal to implement a Medicare billing code, known as G2211, in 2024. ASAM submitted comments to the Centers for Medicare and Medicaid Services (CMS) on the proposed 2024 MPFS and OPPS rules, encouraging CMS to finalize many new Medicare proposals, with several modifications. ASAM joined several other organizations in a letter to the leadership of the House Committee on Oversight and Accountability opposing the U.S. Shipping Equity Act (H.R. 3721) that would allow the U.S. Post Office (USPS) to ship beverage alcohol. ASAM signed a letter supporting the Helping Tobacco Users Quit Act (H.R. 4775), which would ensure Medicaid and Childrens Health Insurance Program (CHIP) enrollees have access to all evidence-based tobacco cessation treatments, including seven Food and Drug Administration-approved medications. Advocated for DEA related clarifications or changes to registration requirements related to the delivery of injectable buprenorphine. Supported S 2919 - Advancing Lifesaving Efforts with Rapid Test Strips for Communities Act (ALERT Communities Act) to help expand access to fentanyl and xylazine test strips, a critical tool to help lower overdose deaths. Supported HR 5506 - Hospitals As Naloxone Distribution Sites (HANDS) Act, which would require Medicare, Medicaid, and TRICARE to cover the cost when medical providers physically hand naloxone to patients who are at risk of an overdose, before they are discharged, at zero cost to the patient. Supported H.R.5163 - Telehealth Response for E-prescribing Addiction Therapy Services Act, which would amend the Controlled Substances Act to allow for the use of telehealth in substance use disorder treatment. Supported S.3006 - SAFE in Recovery Act, which would ensure comprehensive wraparound services for families impacted by substance use disorders. Advocated for reforms to the Child Abuse Prevention and Treatment Act related to pregnant women who take medications for substance use disorder. Advocated for continued telemedicine flexibilities related to medications for substance use disorder.

Client expense: $40,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Natl Drug Control Policy (NDCP), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)

Advocated for increased FY24 funding for HRSA's Addiction Medicine Fellowship Program ($30M) Advocated for increased FY24 funding for HRSA's Substance Use Disorder Treatment and Recovery Loan Repayment Program ($50M) Advocated for (S. 644/H.R. 1359) the Modernizing Opioid Treatment Access Act, which would allow specially registered opioid treatment program clinicians and addiction specialist physicians to prescribe methadone for OUD that can be picked up from pharmacies, subject to federal regulation or guidance on supply of methadone for unsupervised use. Advocated for S. 1165/ HR 2400- the Reentry Act, which would allow states to provide Medicaid coverage to eligible individuals up to 30 days prior to release from incarceration Advocated for HR 3074/S.971 - Due Process Continuity of Care Act, which would amend title XIX of the Social Security Act to remove the Medicaid coverage exclusion for inmates in custody pending disposition of charges, and for other purposes. Worked on draft legislation that would provide Medicare coverage for evidence-based residential SUD services Supported H.R.1502 - Comprehensive Opioid Recovery Centers Reauthorization Act of 2023, in its entirety Advocated for removal of in-person evaluation requirement in proposed telemedicine rules by the DEA and worked on related draft legislation Opposed proposed changes to the STAR-LRP program in S.462 - the Mental Health Professionals Workforce Shortage Loan Repayment Act of 2023 Advocated for removal of a lifetime ban that prevents individuals convicted of a drug felony from receiving Supplemental Nutritional Assistance Program (SNAP) or Temporary Assistance for Needy Families TANF) as part of the next Farm Bill. Advocated for various substance use disorder workforce and coverage policy changes, including some of which appear in H.R. 4531, the Support for Patients and Communities Reauthorization Act. Advocated for certain annual increases for Medicare office based SUD bundled codes. ASAM signed a letter in support of S. 1378, Connecting Our Medical Providers with Links to Expand Tailored and Effective Act (the "COMPLETE Act"), which would advance collaborative care models. ASAM signed a letter sent by a broad coalition of health care clinicians, patient advocates, and other stakeholders, urging Congressional leaders to support the Centers for Medicare and Medicaid Services' (CMS) proposal to implement a Medicare billing code, known as G2211, in 2024. ASAM submitted comments to the Centers for Medicare and Medicaid Services (CMS) on the proposed 2024 MPFS and OPPS rules, encouraging CMS to finalize many new Medicare proposals, with several modifications. ASAM joined several other organizations in a letter to the leadership of the House Committee on Oversight and Accountability opposing the U.S. Shipping Equity Act (H.R. 3721) that would allow the U.S. Post Office (USPS) to ship beverage alcohol. ASAM signed a letter supporting the Helping Tobacco Users Quit Act (H.R. 4775), which would ensure Medicaid and Childrens Health Insurance Program (CHIP) enrollees have access to all evidence-based tobacco cessation treatments, including seven Food and Drug Administration-approved medications. Advocated for DEA related clarifications or changes to registration requirements related to the delivery of injectable buprenorphine. Supported S 2919 - Advancing Lifesaving Efforts with Rapid Test Strips for Communities Act (ALERT Communities Act) to help expand access to fentanyl and xylazine test strips, a critical tool to help lower overdose deaths. Supported HR 5506 - Hospitals As Naloxone Distribution Sites (HANDS) Act, which would require Medicare, Medicaid, and TRICARE to cover the cost when medical providers physically hand naloxone to patients who are at risk of an overdose, before they are discharged, at zero cost to the patient. Supported H.R.5163 - Telehealth Response for E-prescribing Addiction Therapy Services Act, which would amend the Controlled Substances Act to allow for the use of telehealth in substance use disorder treatment. Supported S.3006 - SAFE in Recovery Act, which would ensure comprehensive wraparound services for families impacted by substance use disorders. Advocated for reforms to the Child Abuse Prevention and Treatment Act related to pregnant women who take medications for substance use disorder. Advocated for continued telemedicine flexibilities related to medications for substance use disorder.

Client expense: $40,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Natl Drug Control Policy (NDCP), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)

Advocated for increased FY24 funding for HRSA's Addiction Medicine Fellowship Program ($30M) Advocated for increased FY24 funding for HRSA's Substance Use Disorder Treatment and Recovery Loan Repayment Program ($50M) Advocated for (S. 644/H.R. 1359) the Modernizing Opioid Treatment Access Act, which would allow specially registered opioid treatment program clinicians and addiction specialist physicians to prescribe methadone for OUD that can be picked up from pharmacies, subject to federal regulation or guidance on supply of methadone for unsupervised use. Advocated for S. 1165/ HR 2400- the Reentry Act, which would allow states to provide Medicaid coverage to eligible individuals up to 30 days prior to release from incarceration Advocated for HR 3074/S.971 - Due Process Continuity of Care Act, which would amend title XIX of the Social Security Act to remove the Medicaid coverage exclusion for inmates in custody pending disposition of charges, and for other purposes. Worked on draft legislation that would provide Medicare coverage for evidence-based residential SUD services Supported H.R.1502 - Comprehensive Opioid Recovery Centers Reauthorization Act of 2023, in its entirety Advocated for removal of in-person evaluation requirement in proposed telemedicine rules by the DEA and worked on related draft legislation Opposed proposed changes to the STAR-LRP program in S.462 - the Mental Health Professionals Workforce Shortage Loan Repayment Act of 2023 Advocated for removal of a lifetime ban that prevents individuals convicted of a drug felony from receiving Supplemental Nutritional Assistance Program (SNAP) or Temporary Assistance for Needy Families TANF) as part of the next Farm Bill. Advocated for various substance use disorder workforce and coverage policy changes, including some of which appear in H.R. 4531, the Support for Patients and Communities Reauthorization Act. Advocated for certain annual increases for Medicare office based SUD bundled codes. ASAM signed a letter in support of S. 1378, Connecting Our Medical Providers with Links to Expand Tailored and Effective Act (the "COMPLETE Act"), which would advance collaborative care models. ASAM signed a letter sent by a broad coalition of health care clinicians, patient advocates, and other stakeholders, urging Congressional leaders to support the Centers for Medicare and Medicaid Services' (CMS) proposal to implement a Medicare billing code, known as G2211, in 2024. ASAM submitted comments to the Centers for Medicare and Medicaid Services (CMS) on the proposed 2024 MPFS and OPPS rules, encouraging CMS to finalize many new Medicare proposals, with several modifications. ASAM joined several other organizations in a letter to the leadership of the House Committee on Oversight and Accountability opposing the U.S. Shipping Equity Act (H.R. 3721) that would allow the U.S. Post Office (USPS) to ship beverage alcohol. ASAM signed a letter supporting the Helping Tobacco Users Quit Act (H.R. 4775), which would ensure Medicaid and Childrens Health Insurance Program (CHIP) enrollees have access to all evidence-based tobacco cessation treatments, including seven Food and Drug Administration-approved medications. Advocated for DEA related clarifications or changes to registration requirements related to the delivery of injectable buprenorphine. Supported S 2919 - Advancing Lifesaving Efforts with Rapid Test Strips for Communities Act (ALERT Communities Act) to help expand access to fentanyl and xylazine test strips, a critical tool to help lower overdose deaths. Supported HR 5506 - Hospitals As Naloxone Distribution Sites (HANDS) Act, which would require Medicare, Medicaid, and TRICARE to cover the cost when medical providers physically hand naloxone to patients who are at risk of an overdose, before they are discharged, at zero cost to the patient. Supported H.R.5163 - Telehealth Response for E-prescribing Addiction Therapy Services Act, which would amend the Controlled Substances Act to allow for the use of telehealth in substance use disorder treatment. Supported S.3006 - SAFE in Recovery Act, which would ensure comprehensive wraparound services for families impacted by substance use disorders. Advocated for reforms to the Child Abuse Prevention and Treatment Act related to pregnant women who take medications for substance use disorder. Advocated for continued telemedicine flexibilities related to medications for substance use disorder.

Client expense: $40,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Natl Drug Control Policy (NDCP), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)

Advocated for increased FY24 funding for HRSA's Addiction Medicine Fellowship Program ($30M) Advocated for increased FY24 funding for HRSA's Substance Use Disorder Treatment and Recovery Loan Repayment Program ($50M) Advocated for (S. 644/H.R. 1359) the Modernizing Opioid Treatment Access Act, which would allow specially registered opioid treatment program clinicians and addiction specialist physicians to prescribe methadone for OUD that can be picked up from pharmacies, subject to federal regulation or guidance on supply of methadone for unsupervised use. Advocated for S. 1165/ HR 2400- the Reentry Act, which would allow states to provide Medicaid coverage to eligible individuals up to 30 days prior to release from incarceration Advocated for HR 3074/S.971 - Due Process Continuity of Care Act, which would amend title XIX of the Social Security Act to remove the Medicaid coverage exclusion for inmates in custody pending disposition of charges, and for other purposes. Worked on draft legislation that would provide Medicare coverage for evidence-based residential SUD services Supported H.R.1502 - Comprehensive Opioid Recovery Centers Reauthorization Act of 2023, in its entirety Advocated for removal of in-person evaluation requirement in proposed telemedicine rules by the DEA and worked on related draft legislation Opposed proposed changes to the STAR-LRP program in S.462 - the Mental Health Professionals Workforce Shortage Loan Repayment Act of 2023 Advocated for removal of a lifetime ban that prevents individuals convicted of a drug felony from receiving Supplemental Nutritional Assistance Program (SNAP) or Temporary Assistance for Needy Families TANF) as part of the next Farm Bill. Advocated for various substance use disorder workforce and coverage policy changes, including some of which appear in H.R. 4531, the Support for Patients and Communities Reauthorization Act. Advocated for certain annual increases for Medicare office based SUD bundled codes. ASAM signed a letter in support of S. 1378, Connecting Our Medical Providers with Links to Expand Tailored and Effective Act (the "COMPLETE Act"), which would advance collaborative care models. ASAM signed a letter sent by a broad coalition of health care clinicians, patient advocates, and other stakeholders, urging Congressional leaders to support the Centers for Medicare and Medicaid Services' (CMS) proposal to implement a Medicare billing code, known as G2211, in 2024. ASAM submitted comments to the Centers for Medicare and Medicaid Services (CMS) on the proposed 2024 MPFS and OPPS rules, encouraging CMS to finalize many new Medicare proposals, with several modifications. ASAM joined several other organizations in a letter to the leadership of the House Committee on Oversight and Accountability opposing the U.S. Shipping Equity Act (H.R. 3721) that would allow the U.S. Post Office (USPS) to ship beverage alcohol. ASAM signed a letter supporting the Helping Tobacco Users Quit Act (H.R. 4775), which would ensure Medicaid and Childrens Health Insurance Program (CHIP) enrollees have access to all evidence-based tobacco cessation treatments, including seven Food and Drug Administration-approved medications. Advocated for DEA related clarifications or changes to registration requirements related to the delivery of injectable buprenorphine. Supported S 2919 - Advancing Lifesaving Efforts with Rapid Test Strips for Communities Act (ALERT Communities Act) to help expand access to fentanyl and xylazine test strips, a critical tool to help lower overdose deaths. Supported HR 5506 - Hospitals As Naloxone Distribution Sites (HANDS) Act, which would require Medicare, Medicaid, and TRICARE to cover the cost when medical providers physically hand naloxone to patients who are at risk of an overdose, before they are discharged, at zero cost to the patient. Supported H.R.5163 - Telehealth Response for E-prescribing Addiction Therapy Services Act, which would amend the Controlled Substances Act to allow for the use of telehealth in substance use disorder treatment. Supported S.3006 - SAFE in Recovery Act, which would ensure comprehensive wraparound services for families impacted by substance use disorders. Advocated for reforms to the Child Abuse Prevention and Treatment Act related to pregnant women who take medications for substance use disorder. Advocated for continued telemedicine flexibilities related to medications for substance use disorder.

Client expense: $40,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Natl Drug Control Policy (NDCP), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)